iBio, Inc. Files 8-K: Material Agreement, Exhibits
Ticker: IBIO · Form: 8-K · Filed: Apr 22, 2025 · CIK: 1420720
| Field | Detail |
|---|---|
| Company | Ibio, Inc. (IBIO) |
| Form Type | 8-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, exhibits
TL;DR
iBio filed an 8-K on 4/21/25 for a material agreement. Details to follow.
AI Summary
On April 21, 2025, iBio, Inc. entered into a Material Definitive Agreement. The filing also includes a Regulation FD Disclosure and Financial Statements and Exhibits. The company is incorporated in Delaware and its principal executive offices are located in Bryan, Texas.
Why It Matters
This 8-K filing indicates a significant event for iBio, Inc., likely related to a new contract or partnership, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material Definitive Agreements can introduce new risks or opportunities, and the lack of specific details in this initial filing warrants a medium risk assessment.
Key Players & Entities
- iBio, Inc. (company) — Registrant
- April 21, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Bryan, Texas (location) — Principal Executive Offices
- 001-35023 (identifier) — Commission File Number
- 26-2797813 (identifier) — IRS Employer Identification No.
FAQ
What is the nature of the Material Definitive Agreement entered into by iBio, Inc. on April 21, 2025?
The filing does not specify the nature of the Material Definitive Agreement, only that one was entered into on April 21, 2025.
What are the principal executive offices of iBio, Inc.?
The principal executive offices of iBio, Inc. are located at 8800 HSC Parkway, Bryan, Texas 77807.
When was iBio, Inc. incorporated?
iBio, Inc. was incorporated in Delaware.
What is the Commission File Number for iBio, Inc.?
The Commission File Number for iBio, Inc. is 001-35023.
What other items are included in this 8-K filing besides the Material Definitive Agreement?
This 8-K filing also includes a Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding iBio, Inc. (IBIO).